Celltrion chairman\

South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...

South Korea’s leading asset manager Mirae Asset Financial Group is increasingly unveiling China-focused investment products as Chairman P...

South Korea’s biopharmaceutical giant Celltrion Inc. has solidified its presence in South America after winning supply contracts for its flags...

Chey Tae-won, chairman of SK Group, the parent of SK Hynix Inc., is visiting Taiwan amid the threat of escalating US tariff threats, suggesting the ...

Celltrion Inc. said Wednesday it has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for three biosimilar...

Korea Zinc Inc. Chairman Choi Yun-birm appears to have kept his grip on the world’s largest zinc smelter after successfully fending off an MBK...

MBK Partners sees a recovery in the exit environment in 2025 and seeks to capitalize on the opportunities emerging from corporate governance reform ...

South Korea’s chemical-to-defense conglomerate Hanwha Group Chairman Kim Seung-youn will hand over half of his holdings in the conglomerate&rs...

South Korea’s leading biosimilar drug developer Celltrion Inc. said on Monday it is set to sell Steqeyma, a biosimilar to autoimmune disease t...

BEIJING – Samsung Electronics Co. Chairman Lee Jae-yong has met with Xiaomi Inc. Chief Executive Lei Jun in the Chinese capital, raising specu...

Michael ByungJu Kim, the co-founder, partner and chairman of Northeast Asia-focused private equity firm (PEF) MBK Partners Ltd., is expected to leve...

South Korea’s leading biosimilar drug developer Celltrion Inc. announced on Friday a plan to cancel $140 million worth of treasury shares to i...

Samsung Bioepis Co. and Celltrion Inc. are outpacing long-established global drug manufacturers such as Amgen Inc. and Sandoz in the antibody biosim...

Affinity Equity Partners and Singapore’s sovereign wealth fund GIC have sold their entire stake in Kyobo Life Insurance Co., exiting from thei...

MBK Partners, facing increasing scrutiny over its highly leveraged acquisition of Homeplus Co., has pledged to go all-out to restore the struggling ...

LG Group Chairman Koo Kwang-mo visited LG Electronics Inc.'s factory and research center in India in late February as it plans to list its Indian ar...

Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...

Mirae Asset Financial Group is preparing to launch a bitcoin covered call exchange traded fund (ETF) for global investors to foray into the cryptocu...

LG AI Research Institute, the artificial intelligence think-tank of LG Group, South Korea’s fourth-biggest conglomerate, on Thursday signed a ...

South Korea’s leading biosimilar drug developer Celltrion Inc.'s Vegzelma, a cancer drug referencing global biopharma Roche’s Avastin, h...

Samsung Electronics Co. Chairman Lee Jae-yong was found not guilty of accounting fraud, stock manipulation and other criminal charges by a Seoul app...

South Korea’s largest shipbuilder HD Korea Shipbuilding & Offshore Engineering Co. (HD KSOE) said on Thursday it got 3.716 trillion won ...

SAN FRANCISCO – South Korea’s leading biosimilar drug developer Celltrion Inc. seeks to acquire a domestic health food maker as early as...

LAS VEGAS – SK Hynix Inc., the world’s second-largest memory chipmaker, has agreed to collaborate with Nvidia Corp. on the top US AI chi...

South Korea’s Financial Supervisory Service (FSS) has reported Korea Zinc Inc.'s Chairman Choi Yun-birm and its board of directors to prosecut...

South Korea’s two leading drugmakers, Celltrion Inc. and Samsung Bioepis Co., have achieved a significant milestone in the European biosimilar...

Hanmi Pharmaceutical Group Chairman Song Young-sook is poised to claim victory in a year-long dispute with her eldest son Lim Jong-yoon to take cont...

Chung Yong-jin, the chairman of South Korea’s retail giant Shinsegae Group, held talks with US President-elect Donald Trump, becoming Korea's ...

South Korea's Celltrion Inc. said on Wednesday it received new drug submission (NDS) approval from the Food and Drug Administration (FDA) for Steq...

Celltrion Inc. on Tuesday launched its contract development and manufacturing organization unit Celltrion BioSolutions Co. in its foray into the CDM...